Marek Chawarski, PhD
Professor of Psychiatry and Emergency MedicineCards
Additional Titles
Affiliated Faculty, Yale Institute for Global Health
Contact Info
Psychiatry
CMHC/SAC, 34 Park Street
New Haven, CT 06519
United States
Appointments
Additional Titles
Affiliated Faculty, Yale Institute for Global Health
Contact Info
Psychiatry
CMHC/SAC, 34 Park Street
New Haven, CT 06519
United States
Appointments
Additional Titles
Affiliated Faculty, Yale Institute for Global Health
Contact Info
Psychiatry
CMHC/SAC, 34 Park Street
New Haven, CT 06519
United States
About
Titles
Professor of Psychiatry and Emergency Medicine
Affiliated Faculty, Yale Institute for Global Health
Appointments
Emergency Medicine
ProfessorFully JointPsychiatry
ProfessorFully Joint
Other Departments & Organizations
Education & Training
- PhD
- Yale University (1995)
- MPhil
- Yale University, Psychology (1993)
- MS
- Yale University, Psychology/Cognitive (1992)
- MA
- Jagiellonian University, Psychology/Clinical, Cognitive (1987)
Research
Overview
Medical Research Interests
ORCID
0000-0001-6254-3092
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Patrick G. O'Connor, MD, MPH, MACP
Gail D'Onofrio, MD, MS
David Fiellin, MD
Edouard Coupet II, MD, MS
Kathryn Hawk, MD, MHS
Declan Barry, PhD
Opioid-Related Disorders
Malaysia
Risk-Taking
China
Substance Abuse Detection
Amphetamine-Related Disorders
Publications
2025
Unintended Prolonged Opioid Use: Protocol for a Case-Controlled Trial.
Hooten W, Erickson D, Chawarski M, Scholz N, Waljee J, Brummett C, Jeffery M. Unintended Prolonged Opioid Use: Protocol for a Case-Controlled Trial. JMIR Research Protocols 2025, 14: e72032. PMID: 39992690, DOI: 10.2196/72032.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsINTERNATIONAL REGISTERED REPORT IDENTIFIERElectronic health record systemsPatient recruitmentPractice environment characteristicsPrescribing opioids to patientsOpioid prescriptionsHealth record systemsPatient characteristicsContinuation of opioid therapyIndividual practice environmentsOpioids to patientsOpioid-naive adultsOpioid-naive patientsProlonged opioid useSelf-report surveyNational administrative claims databaseMisuse of prescription opioidsCOVID-19 pandemicPublic health problemClinician recruitmentCase-control trialShort-term useAdministrative claims databaseMayo Clinic sitesCTSA programT57 Integrating MOUD in Non-Medical Community Organizations: Better Together MOUD (BT-MOUD)
Scott D, Schottenfeld R, Clover E, Curry K, Waites S, Cain G, Patton M, Pattrick M, Jordan D, Bulluck K, Chawarski M. T57 Integrating MOUD in Non-Medical Community Organizations: Better Together MOUD (BT-MOUD). Drug And Alcohol Dependence 2025, 267: 111825. DOI: 10.1016/j.drugalcdep.2024.111825.Peer-Reviewed Original ResearchBarriers and Facilitators for Engaging and Retaining Black Persons in Medications for Opioid Use Disorder (MOUD)
Schottenfeld R, Scott D, Medlock M, Waites S, Brown I, Borba C, Patton M, Pattrick M, Cain G, Williams C, Magidson J, Chawarski M. Barriers and Facilitators for Engaging and Retaining Black Persons in Medications for Opioid Use Disorder (MOUD). Drug And Alcohol Dependence 2025, 267: 112232. DOI: 10.1016/j.drugalcdep.2024.112232.Peer-Reviewed Original ResearchConceptsM80 Temporal Trends in NGO-based Supportive Services and HIV Rates Among PWID in Malaysia Between 2012 and 2022
Kasinather V, Khan S, Abdullah M, Yusoff N, Jalil J, Schottenfeld R, Chawarski M. M80 Temporal Trends in NGO-based Supportive Services and HIV Rates Among PWID in Malaysia Between 2012 and 2022. Drug And Alcohol Dependence 2025, 267: 111674. DOI: 10.1016/j.drugalcdep.2024.111674.Peer-Reviewed Original ResearchConcepts
2024
Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E, Hawk K, Huntley K, Jalali A, O'Connor P, Owens P, Martel S, Fiellin D, D'Onofrio G, Murphy S. Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. Annals Of Emergency Medicine 2024, 85: 205-213. PMID: 39570250, PMCID: PMC11845297, DOI: 10.1016/j.annemergmed.2024.10.001.Peer-Reviewed Original ResearchConceptsHealth care sector perspectiveImplementation facilitatorsOpioid use disorder careIncremental cost-effectiveness ratioCost-effectiveness ratioHealth care sector costsEducational strategiesImplementation facilitation strategyCost-effectiveness acceptability curvesLikelihood of cost-effectivenessCost-effectiveOpioid use disorderQuality-adjusted life yearsUse disorderPatient engagementAcademic EDED visitsAcceptability curvesStandard educationEmergency departmentLife yearsFacilitation strategiesMeasures of effectivenessHealthBuprenorphine403EMF Barriers and Facilitators to Addiction Treatment Access From the Emergency Department Among Black Individuals With Opioid Use Disorder
Coupet E, Chawarski M, Hercules K, Williams J, Murphy A, Owens P, D'Onofrio G. 403EMF Barriers and Facilitators to Addiction Treatment Access From the Emergency Department Among Black Individuals With Opioid Use Disorder. Annals Of Emergency Medicine 2024, 84: s182-s183. DOI: 10.1016/j.annemergmed.2024.08.403.Peer-Reviewed Original ResearchM162 Phytochemical Composition of Fresh Kratom Leaves Collected in the Northern Region of Malaysia
Karunakaran T, Kasinather V, Chawarski M. M162 Phytochemical Composition of Fresh Kratom Leaves Collected in the Northern Region of Malaysia. Drug And Alcohol Dependence 2024, 260: 110442. DOI: 10.1016/j.drugalcdep.2023.110442.Peer-Reviewed Original ResearchW81 Implementation Facilitation Improves Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine in Four Urban Academic Centers
Hawk K, D'Onofrio G, Chawarski M, Coupet E, Cowan E, Curry L, Freiermurth C, Lyons M, Murphy A, O'Connor P, Richardson L, Rothman R, Whiteside L, Williams J, Fiellin D, Edelman E. W81 Implementation Facilitation Improves Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine in Four Urban Academic Centers. Drug And Alcohol Dependence 2024, 260: 110699. DOI: 10.1016/j.drugalcdep.2023.110699.Peer-Reviewed Original ResearchT45 Changing Characteristics of HIV/AIDS Epidemic in Malaysia
Kasinather V, Ramadah R, Singh D, Chooi W, Zaharim N, Chawarski M. T45 Changing Characteristics of HIV/AIDS Epidemic in Malaysia. Drug And Alcohol Dependence 2024, 260: 110494. DOI: 10.1016/j.drugalcdep.2023.110494.Peer-Reviewed Original ResearchPhytochemical analysis of water and ethanol liquid extracts prepared using freshly harvested leaves of Mitragyna speciosa (Korth.)
Karunakaran T, Vicknasingam B, Chawarski M. Phytochemical analysis of water and ethanol liquid extracts prepared using freshly harvested leaves of Mitragyna speciosa (Korth.). Natural Product Research 2024, ahead-of-print: 1-8. PMID: 38842220, DOI: 10.1080/14786419.2024.2362428.Peer-Reviewed Original ResearchConceptsFreshly harvested leavesPhytochemical compositionO-coumaric acidDried leaf materialLiquid extractionSpectrum of phytochemicalsKratom leavesBioactive phenolicsChlorogenic acidPhytochemical analysisWater extractLeaf materialLeavesLCMS/MS analysisAnalysis of waterMass spectraFreshlyExtractionLeaves of Mitragyna speciosaSpectrometric methodOxidized derivativesRutinQuercitrinAcidPhytochemicals
Academic Achievements & Community Involvement
activity Substance abuse treatment
ResearchDetails11/01/2010 - 10/31/2017Wuhan, Hubei, ChinaAbstract/SynopsisA study entitled "Behavioral Drug and HIV Risk Reduction Counseling with MMT in China" will provide critical data regarding the efficacy for reducing drug-and sex-related HIV transmission risk behaviors, as well as improving MMT outcomes and patient functioning of two transportable counseling models, behavioral drug and HIV risk reduction counseling (BDRC) and educational counseling (EC) as compared with the current standard of care model in MMT in China.
activity Heroin Dependence
ResearchDetails01/01/2008 - 10/31/2017Tehran, Tehran Province, Iran; Muar, Johor, MalaysiaAbstract/SynopsisProfessor Schottenfeld has established research projects in Malaysia and Iran which are aimed at evaluating treatments for heroin or other opiate dependence and are comparing the efficacy of maintenance treatment with buprenorphine or naltrexone.
activity Substance abuse treatment
ResearchDetails01/01/2010 - 06/30/2017Saint Petersburg, St.-Petersburg, RussiaAbstract/SynopsisA study entitled "Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia" will examine the effects of combining behavioral therapy with naltrexone pharmacotherapy for the treatment of opiate dependence and reduction of HIV risks in opiate dependent individuals in St. Petersburg, Russia.
activity Prevention of HIV Infection among Opiate Dependent Injectors - Phase III Randomized Controlled Trial to Evaluate the Efficacy of buprenorphine/naloxone drug treatment in p
ResearchDetails01/01/2008 - 09/30/2015Beijing, China; Chiang Mai, จ.ร้à¸à¸¢à¹€à¸à¹‡à¸”, Thailand; Nanning, Guangxi, China +1 moreAbstract/SynopsisThe purpose of the study is to determine the efficacy of a drug treatment intervention (buprenorphine/naloxone) in the prevention of HIV transmission among opiate dependent injectors by reducing drug use and associated risk behaviors. URL: http://www.hptn.org/research_studies/hptn058.asp
honor Honorary Guest Professorship
International AwardCentral South University, Changsha, ChinaDetails09/01/2015China
News
News
- June 06, 2024Source: Natural Product Research
Phytochemical Analysis of Water and Ethanol Liquid Extracts Prepared Using Freshly Harvested Leaves of Mitragyna Speciosa (Korth.)
- December 13, 2022
Department of Emergency Medicine Congratulates Four Faculty on Recent Promotions
- January 30, 2022Source: Connecticut Health I-Team
Calls To Rethink The War On Opioids
- December 19, 2019Source: Health Affairs
For Hospitals, A Blueprint For Fighting The Opioid Epidemic
Get In Touch
Contacts
Psychiatry
CMHC/SAC, 34 Park Street
New Haven, CT 06519
United States